Arch Pharm Res Vol 33, No 3, 491-495, 2010
DOI 10.1007/s12272-010-0320-4
491
Capillary Electrophoretic Separation of Poly(ethylene glycol)-
Modified Granulocyte-Colony Stimulating Factor
Kyung Soo Lee and Dong Hee Na
College of Pharmacy, Kyungsung University, Busan 608-736, Korea
(Received November 17, 2009/Revised December 23, 2009/Accepted January 18, 2010)
We evaluated the utility of capillary electrophoretic methods for analyzing poly(ethylene gly-
col) (PEG)-modified granulocyte-colony stimulating factor (G-CSF), a long-acting form of G-
CSF for the treatment of cancer therapy-induced neutropenia. Low- and high-molecular-
weight PEG-G-CSF conjugates prepared with aldehyde-activated PEG-5K and PEG-20K were
separated by high-performance size-exclusion chromatography (HP-SEC), capillary zone elec-
trophoresis (CZE), and sodium dodecyl sulfate-capillary gel electrophoresis (SDS-CGE). HP-
SEC showed low resolution for separating mono- and di-PEG-G-CSFs. SDS-CGE had higher
resolution, but required a long analysis and had low peak efficiency. CZE could successfully
separate both PEG-5K- and PEG-20K-conjugated G-CSFs with a running time of 20 min and
high peak efficiency. In conclusion, CZE was better than SDS-CGE for separating PEG-G-CSF
conjugates and will be useful for PEGylation studies, such as reaction monitoring for optimi-
zation of the PEGylation reaction, and purity and stability tests of PEG-G-CSF.
Key words: PEGylation, Granulocyte-colony stimulating factor, Capillary electrophoresis
INTRODUCTION
Granulocyte-colony stimulating factor (G-CSF) is a
growth factor that regulates proliferation and differ-
entiation of neutrophilic granulocytes. Recombinant
human G-CSF is marketed by Amgen as Neupogen®
(Filgrastim), and is widely used to treat neutropenia
induced by myelosuppressive chemotherapy (Buchsel
et al., 2002). However, the clinical use of Neupogen is
limited due to a short circulation half-life (3.5~3.8 h)
that requires a daily injection (Frampton et al., 1994).
The covalent modification of protein with poly(ethy-
lene glycol) (PEG), termed PEGylation, is useful for
increasing the circulation half-life and decreasing the
dosing frequency (Kang et al., 2009). Neulasta® (pegfi-
lgrastim), also developed by Amgen, is PEGylated G-
CSF produced by the attachment of a 20 kDa mono-
methoxy PEG-aldehyde to the N-terminal amine of G-
CSF (Piedmonte and Treuheit, 2008). This modifica-
tion significantly increases circulation half-life and
only needs to be dosed once per chemotherapy cycle,
as opposed to repeated daily injection for G-CSF
(Kinstler et al., 2002; Molineux, 2003).
PEGylated proteins are among the most challenging
products in pharmaceutical analysis, because the
PEGylation process results in molecular heterogeneity
in terms of the number and positions of attached PEG
molecules (Park and Na, 2008; Park et al., 2009). As
these heterogeneities may confer different biological
properties, the development of analytical methods for
PEGylated proteins is becoming more important (Fee
and Van Alstine, 2006). Capillary electrophoresis (CE)
shows high separation capacity for proteins and their
conjugates (Na and Lee, 2007). Several investigators
have used capillary zone electrophoresis (CZE) for the
analysis of several PEGylated forms of proteins, such
as superoxide dismutase, lysozyme, ribonuclease A,
and human parathyroid hormone (1-34) (Bullock et
al., 1996; Roberts and Harris, 1998; Li et al., 2001; Na
and Lee, 2004). Recently, we reported the use of
sodium dodecyl sulfate-capillary gel electrophoresis
(SDS-CGE) using a hydrophilic replaceable polymer
network matrix for the separation of PEGylated inter-
ferons (Na et al., 2004, 2008).
Correspondence to: Dong Hee Na, College of Pharmacy, Kyung-
sung University, Busan 608-736, Korea
Tel: 82-51-663-4881, Fax: 82-51-663-4809
E-mail: dhna2@ks.ac.kr
492 K. S. Lee and D. H. Na
Here, we used both CZE and SDS-CGE methods for
the analysis of PEGylated G-CSF produced by a reac-
tion with aldehyde-activated PEG. PEGylated G-CSFs
were prepared with low (5 kDa)- and high (20 kDa)-
molecular-weight-PEGs and the two methods were
compared based on analysis time, peak efficiency, and
resolution.
MATERIALS AND METHODS
Materials and reagents
Recombinant human granulocyte-colony stimulating
factor (G-CSF) (MW 18,800) was a gift from Dong-A
Pharmaceutical Co. Ltd. Monomethoxy PEG-butyral-
dehydes (mPEG-ALD, MW 5 or 20 kDa) were pur-
chased from Nektar Therapeutics. A micro BCA pro-
tein assay kit was obtained from Pierce. Capillary
electrophoresis buffer (0.1 M phosphate buffer, pH
2.5) and sodium cyanoborohydride were obtained from
Sigma. All other chemicals were of analytical grade
and were used as obtained commercially.
PEGylation of G-CSF
The PEGylation of G-CSF was performed with
mPEG-ALD (MW 5 or 20 kDa) in the presence of
sodium cyanoborohydride (NaCNBH3) at pH 5, as
described previously (Kinstler et al., 2002; Na et al.,
2006). Briefly, PEG solutions were prepared by adding
4.4 mg of mPEG-ALD-5K (MW 5 kDa) or 17.6 mg of
mPEG-ALD-20K (MW 20,000) to 1 mL of 0.1 M sodium
acetate buffer (pH 5.0) containing 40 mM NaCNBH3.
The PEG solutions were added to 1 mL of G-CSF
solution (3.3 mg/mL in 0.1 M sodium acetate buffer,
pH 5.0) at a molar ratio of G-CSF:mPEG-ALD=1:5, and
the reaction was continued for 18 h at 4oC. The mono-
PEGylated G-CSF (mono-PEG-G-CSF) was isolated
by size-exclusion chromatography on a Superose 12
10/300 GL column (Amersham Biosciences) with 10
mM sodium phosphate buffer saline (PBS) (pH 7.4) as
the mobile phase. The flow rate was 0.4 mL/min and
the UV absorbance was monitored at 215 nm. The
purified mono-PEG-G-CSF was concentrated with
Amicon centricon 10 (molecular weight cut-off 10 kDa,
Millipore) and the protein concentration was deter-
mined by the micro BCA assay (Smith et al., 1985).
High-performance size-exclusion chromato-
graphy (HP-SEC)
Analytical HP-SEC was performed using a Dionex
HPLC system (Dionex Co.) consisted of a quaternary
gradient pump with an on-line vacuum degasser
(Model P680A), an automated sample injector (Model
ASI-100), thermostatic column compartment (Model
TCC-100), and 4-channel multi UV-Vis detector (Model
170U). Separations were performed on a Shodex
Protein KW 802.5 column (8.0 mm i.d. ×300 mm, silica
particle 5 µm, Showa Denko) using 10 mM sodium
phosphate buffer (pH 7.4) as a mobile phase. Sample
injection volume was 20 µL and the flow rate was 1
mL/min. UV absorbance was monitored at 215 nm.
Capillary zone electrophoresis (CZE)
CE experiments were performed on a P/ACETM MDQ
capillary electrophoresis system (Beckman Coulter
Inc.). CZE was performed with a BioCap bare silica
capillary, 75 µm i.d., 32 cm total length, and 22 cm to
the detector (Bio-Rad). Separation of each sample was
performed in 100 mM phosphate buffer (pH 2.5) as
the electrolyte for 20 min, and the UV absorbance was
measured at 214 nm. The capillary was rinsed with
0.1 M NaOH, deionized water and 100 mM phosphate
buffer (pH 2.5) for 120, 120, and 180 sec, respectively,
prior to each injection. Samples were loaded by
applying a nitrogen pressure of 0.5 psi for 5 sec, and
the voltage across the ends of the capillary was set at
10 kV. The temperature of the capillary and samples
was maintained at 20oC by a liquid cooling system.
SDS-capillary gel electrophoresis (SDS-CGE)
SDS-CGE was performed with an eCAP SDS 14-200
Kit using a coated capillary with 100 µm i.d., 30 cm
total length, and 20 cm to the detection window
(Beckman Coulter). Prior to each sample injection, the
capillary was rinsed with 1 M HCl and gel buffer for
60 and 180 sec, respectively. Two additional purges
for 0 sec with a mixture of sample buffer (0.12 M Tris/
HCl/1% SDS) and deionized water (1:1) was perform-
ed to wash any residual running buffer from the outlet
surface of the capillary prior to sample injection. The
samples for CE analysis were prepared by mixing 100
mL of the sample with 100 mL of sample buffer.
Samples were heated at 100oC in a water bath for 10
min and then cooled on ice for 3 min, followed by
centrifugation. Samples were injected by applying a
nitrogen pressure of 0.5 psi for 30 sec, and the voltage
across the ends of the capillary was set at 8-15 kV. UV
absorbance was monitored at 214 nm for 20-40 min.
The capillary temperature was maintained at 20oC by
the liquid cooling system.
RESULTS AND DISCUSSION
G-CSF has five primary amines in the N-terminus
and four lysine residues (Lys17, Lys24, Lys35, and
Lys41) that are potential PEGylation sites. Neulasta
(pegfilgrastim) is PEGylated G-CSF produced by the
Capillary Electrophoresis of PEG-G-CSF 493
attachment of mPEG-ALD-20K to the N-terminal
amine of G-CSF. In this study, PEGylation of G-CSF
was performed by a similar method with mPEG-ALD-
5K or 20K (Fig. 1).
Fig. 2 shows the HP-SEC chromatograms of native
G-CSF and PEGylation reaction mixtures between G-
CSF and mPEG-ALD-5K or 20K at a molar ratio of G-
CSF:PEG=1:5 for 18 h at 4oC. G-CSF was converted to
the mono-PEG conjugate and di-PEG conjugate by the
reaction with mPEG-ALD. Native G-CSF was detect-
ed at a retention time of approximately 8.9 min, and
the mono- and di-PEG-5K-G-CSFs were detected at
7.6 and 7.0 min, respectively (Fig. 2B). The mono- and
di-PEG-20K-G-CSFs were detected at 6.4 and 6.0 min,
respectively (Fig. 2C). The production yields of mono-
PEG-G-CSF were 87% with mPEG-ALD-5K and 80.4%
with mPEG-ALD-20K.
Capillary zone electrophoresis (CZE) was performed
with an uncoated silica capillary using 100 mM phos-
phate buffer (pH 2.5) as the electrolyte. The standard
G-CSF was detected as a single peak at a migration
time of 4.3 min (Fig. 3). The calibration curve of G-
CSF was obtained from 18 to 1130 µg/mL, with a
correlation coefficient greater than 0.998. Fig. 4 shows
the CE electropherograms of the PEGylation reaction
mixture of PEG-5K-G-CSF and the isolated mono-
PEG-5K-G-CSF. As demonstrated previously, the
separation in CZE using acidic buffer is dominated by
the size of PEGylated protein because the acidic pH
produces complete protein protonation and minimizes
the charge difference (Na and Lee, 2004). The PEG-G-
CSF showed lower electrophoretic mobility because of
the increased hydrodynamic radius. The mono- and
di-PEG-5K-G-CSFs were detected at migration times
of 7.5 and 9.6 min, respectively, with a resolution of
1.62 (Fig. 4A). The migration times of PEG-20K-G-
CSF conjugates were significantly prolonged (Fig. 5),
with mono- and di-PEG-20K-G-CSFs detected at
migration times of 10.3 and 16.4 min, respectively.
The isolated mono-PEG-20K-G-CSF had satisfactory
purity (Fig. 5B), with mono-PEG-5K- and mono-PEG-
20K-G-CSFs concentrations of 45.5 and 139.9 µg/mL,
respectively.
SDS-capillary gel electrophoresis (SDS-CGE) can
separate PEGylated interferons, with advantages of
speed, minimal sample consumption, and higher
Fig. 1. Reaction of primary amines of G-CSF with mPEG-
ALD in the presence of sodium cyanoborohydride (NaCNBH3)
Fig. 3. CZE electropherogram of G-CSF
Fig. 2. HP-SEC chromatograms of native G-CSF (A), re-
action mixture between G-CSF and mPEG-ALD-5K (B), and
reaction mixture between G-CSF and mPEG-ALD-20K (C).
Peak 1: unmodified G-CSF, 2: mono-PEG-5K-G-CSF, 3: di-
PEG-5K-G-CSF, 4: mono-PEG-20K-G-CSF, and 5: di-PEG-
20K-G-CSF.
494 K. S. Lee and D. H. Na
resolution than conventional SDS-PAGE (Na et al.,
2004, 2008). Fig. 6 shows the SDS-CGE electropherog-
rams of the PEGylation reaction mixture between G-
CSF and mPEG-ALD-5K obtained by different voltages
across the capillary. As SDS-CGE separates proteins
by size, peaks 2 and 3 were assigned to mono- and di-
PEG-5K-G-CSF, respectively. As capillary voltage in-
creases from 8 to 12 kV, the migration times of every
peaks became faster, but the resolutions were not
significantly changed. The resolutions of peaks 1-2
and 2-3 at 8 kV were 1.86 and 1.25, respectively,
whereas those of peaks 1-2 and 2-3 at 12 kV were 1.87
and 1.30, respectively. Although the recommended
voltage is 8 kV, 12 kV showed faster run time with no
loss in resolution. The SDS-CGE separation of PEG-
20K-G-CSF conjugates required more time time (Fig.
7): at 12 kV, mono-PEG-20K-G-CSF was detected at
25.0 min and di-PEG-20K-G-CSF was not detected
until 40 min. At 15 kV, mono- and di-PEG-20K-G-CSFs
were detected at 19.5 and 33.7 min, respectively.
Higher voltage caused excessive Joule heat in the
capillary.
In conclusion, CE methods showed better separation
capacity than HP-SEC for the separation of PEG-G-
CSFs. The CZE method could separate successfully
Fig. 4. CZE electropherograms of reaction mixtures between
G-CSF and mPEG-ALD-5K (A), and the isolated mono-
PEG-5K-G-CSF (B). Peak 1: unmodified G-CSF, 2: mono-
PEG-5K-G-CSF, and 3: di-PEG-5K-G-CSF.
Fig. 5. CZE electropherograms of reaction mixtures between
G-CSF and mPEG-ALD-20K (A), and the isolated mono-
PEG-20K-G-CSF (B). Peak 1: unmodified G-CSF, 2: mono-
PEG-20K-G-CSF, and 3: di-PEG-20K-G-CSF.
Fig. 6. SDS-CGE electropherograms of reaction mixtures
between G-CSF and mPEG-ALD-5K obtained with running
voltages of 8 kV (A), 10 kV (B), and 12 kV (C). Peak 1: un-
modified G-CSF, 2: mono-PEG-5K-G-CSF, and 3: di-PEG-
5K-G-CSF.
Fig. 7. SDS-CGE electropherograms of reaction mixtures
between G-CSF and mPEG-ALD-20K obtained with runn-
ing voltages of 12 kV (A) and 15 kV (B). Peak 1: unmodified
G-CSF, 2: mono-PEG-20K-G-CSF, and 3: di-PEG-20K-G-CSF.
Capillary Electrophoresis of PEG-G-CSF 495
both PEG-5K- and PEG-20K-conjugated G-CSFs with
a running time of 20 min. The SDS-CGE method was
useful for the separation of low-molecular-weight
PEG-5K-conjugated G-CSFs, but not for high-mole-
cular-weight PEG-20K-conjugated G-CSF because of
long migration times and low peak efficiency. The
sensitivity of the CZE method was superior to the
SDS-CGE method. The CZE method will be useful for
studies of G-CSF PEGylation, such as reaction moni-
toring for optimization of PEGylation reaction, purity
tests, and stability tests.
ACKNOWLEDGEMENTS
This work was financially supported by the Ministry
of Knowledge Economy (MKE) and Korea Institute for
Advancement in Technology (KIAT) through the Work-
force Development Program in Strategic Technology.
REFERENCES
Buchsel, P. C., Forgey, A., Grape, F. B., and Hamann, S. S.,
Granulocyte macrophage colony-stimulating factor: cur-
rent practice and novel approaches. Clin. J. Oncol. Nurs.,
6, 198-205 (2002).
Bullock, J., Chowdhury, S., and Johnston, D., Characteri-
zation of poly(ethylene glycol)-modified superoxide dis-
mutase: comparison of capillary electrophoresis and matrix-
assisted laser desorption/ionization mass spectrometry.
Anal. Chem., 68, 3258-3264 (1996).
Fee, C. J. and Van Alstine, J. M., PEG-proteins: reaction
engineering and separation issues. Chem. Eng. Sci., 61,
924-939 (2006).
Frampton, J. E., Lee, C. R., and Faulds, D., Filgrastim. A
review of its pharmacological properties and therapeutic
efficacy in neutropenia. Drugs, 48, 731-760 (1994).
Kang, J. S., Deluca, P. P., and Lee, K. C., Emerging
PEGylated drugs. Expert Opin. Emerg. Drugs, 14, 363-
380 (2009).
Kinstler, O. B., Brems, D. N., Lauren, S. L., Paige, A. G.,
Hamburger, J. B., and Treuheit, M. J., Characterization
and stability of N-terminally PEGylated rhG-CSF.
Pharm. Res., 13, 996-1002 (1996).
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., and Gegg,
C., Mono-N-terminal poly(ethylene glycol)-protein con-
jugates. Adv. Drug Deliv. Rev., 54, 477-485 (2002).
Li, W., Zhong, Y., Lin, B., and Su, Z., Characterization of
polyethylene glycol-modified proteins by semi-aqueous
capillary electrophoresis. J. Chromatogr. A., 905, 299-307
(2001).
Molineux G., Pegfilgrastim: using pegylation technology to
improve neutropenia support in cancer patients. Anti-
cancer Drugs, 14, 259-264 (2003).
Na, D. H. and Lee, K. C., Capillary electrophoretic charac-
terization of PEGylated human parathyroid hormone
with matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry. Anal. Biochem., 331, 322-328
(2004).
Na, D. H. and Lee, K. C., Capillary separation techniques, In
Gad, S. C. (Ed.). Handbook of Pharmaceutical Biotechno-
logy. John Wiley & Sons, Inc., New Jersey, pp. 469-510,
(2007).
Na, D. H., Park, E. J., Youn, Y. S., Moon, B. W., Jo, Y. W.,
Lee, S. H., Kim, W. B., Sohn Y., and Lee, K. C., Sodium
dodecyl sulfate-capillary gel electrophoresis of polyethy-
lene glycolylated interferon alpha. Electrophoresis, 25,
476-479 (2004).
Na, D. H., Park, E. J., Jo, Y. W., and Lee, K. C., Capillary
electrophoretic separation of high-molecular-weight poly
(ethylene glycol)-modified proteins. Anal. Biochem., 373,
207-212 (2008).
Na, D. H., Youn, Y. S., Lee, I. B., Park, E. J., Park, C. J., and
Lee, K. C., Effect of molecular size of PEGylated recom-
binant human epidermal growth factor on the biological
activity and stability in rat wound tissue. Pharm. Dev.
Technol., 11, 513-519 (2006).
Park, E. J., Lee, K. C., and Na, D. H., Separation of posi-
tional isomers of mono-poly(ethylene glycol)-modified
octreotides by reversed-phase high-performance liquid
chromatography. J. Chromatogr. A., 1216, 7793-7797 (2009).
Park, E. J. and Na, D. H., Optimization of octreotide
PEGylation by monitoring with fast reversed-phase high-
performance liquid chromatography. Anal. Biochem., 380,
140-142 (2008).
Piedmonte, D. M. and Treuheit, M. J., Formulation of
Neulasta (pegfilgrastim). Adv. Drug Deliv. Rev., 60, 50-58
(2008).
Roberts, M. J. and Harris, J. M., Attachment of degradable
poly(ethylene glycol) to proteins has the potential to
increase therapeutic efficacy. J. Pharm. Sci., 87, 1440-
1445 (1998).
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K.,
Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke,
N. M., Olson, B. J., and Klenk, D. C., Measurement of
protein using bicinchoninic acid. Anal. Biochem., 150, 76-
85 (1985).
<<
/ASCII85EncodePages false
/AllowTransparency false
/AutoPositionEPSFiles true
/AutoRotatePages /None
/Binding /Left
/CalGrayProfile (Gray Gamma 2.2)
/CalRGBProfile (sRGB IEC61966-2.1)
/CalCMYKProfile (U.S. Web Coated \050SWOP\051 v2)
/sRGBProfile (sRGB IEC61966-2.1)
/CannotEmbedFontPolicy /Error
/CompatibilityLevel 1.3
/CompressObjects /Off
/CompressPages true
/ConvertImagesToIndexed true
/PassThroughJPEGImages false
/CreateJDFFile false
/CreateJobTicket false
/DefaultRenderingIntent /Default
/DetectBlends true
/ColorConversionStrategy /LeaveColorUnchanged
/DoThumbnails false
/EmbedAllFonts true
/EmbedJobOptions true
/DSCReportingLevel 0
/EmitDSCWarnings false
/EndPage -1
/ImageMemory 1048576
/LockDistillerParams true
/MaxSubsetPct 100
/Optimize true
/OPM 1
/ParseDSCComments true
/ParseDSCCommentsForDocInfo true
/PreserveCopyPage true
/PreserveEPSInfo true
/PreserveHalftoneInfo false
/PreserveOPIComments false
/PreserveOverprintSettings true
/StartPage 1
/SubsetFonts false
/TransferFunctionInfo /Apply
/UCRandBGInfo /Remove
/UsePrologue false
/ColorSettingsFile (Color Management Off)
/AlwaysEmbed [ true
]
/NeverEmbed [ true
]
/AntiAliasColorImages false
/DownsampleColorImages true
/ColorImageDownsampleType /Bicubic
/ColorImageResolution 200
/ColorImageDepth 8
/ColorImageDownsampleThreshold 1.00000
/EncodeColorImages true
/ColorImageFilter /FlateEncode
/AutoFilterColorImages false
/ColorImageAutoFilterStrategy /JPEG
/ColorACSImageDict <<
/QFactor 0.15
/HSamples [1 1 1 1] /VSamples [1 1 1 1]
>>
/ColorImageDict <<
/QFactor 0.15
/HSamples [1 1 1 1] /VSamples [1 1 1 1]
>>
/JPEG2000ColorACSImageDict <<
/TileWidth 256
/TileHeight 256
/Quality 30
>>
/JPEG2000ColorImageDict <<
/TileWidth 256
/TileHeight 256
/Quality 30
>>
/AntiAliasGrayImages false
/DownsampleGrayImages true
/GrayImageDownsampleType /Bicubic
/G
本文档为【PEG-GCSF的毛细管电泳分离】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑,
图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
该文档来自用户分享,如有侵权行为请发邮件ishare@vip.sina.com联系网站客服,我们会及时删除。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。
本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。
网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。